Rulemaking History for OTC Benign Prostatic Hypertrophy Drug Products View by Date
Final Monographs (21 CFR
310.532):
Drug products containing active ingredients offered over-the-counter (OTC)
to relieve the symptoms of benign prostatic hypertrophy
|
Back to Top
Back to Rulemaking Index
Date created: December 28, 2006; Last updated: May 4, 2007 |